<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04960410</url>
  </required_header>
  <id_info>
    <org_study_id>LM2018072</org_study_id>
    <nct_id>NCT04960410</nct_id>
  </id_info>
  <brief_title>Real Time Early Warning Model and Mobile Medical Assistant System for the Impact of Air Pollution on AECOPD Disease</brief_title>
  <official_title>Real Time Early Warning Model and Mobile Medical Assistant System for the Impact of Air Pollution on Acute Exacerbation of Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beihang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective to establish a real-time early warning model of acute exacerbation of chronic&#xD;
      obstructive pulmonary disease (COPD) caused by air pollution, and develop the corresponding&#xD;
      mobile medical assistant system. Through the cross fusion of existing information technology&#xD;
      and medical research results, an auxiliary medical system is formed for information&#xD;
      recording, tracking tools, early warning model and clinical diagnosis of patients with COPD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective to establish a real-time early warning model of acute exacerbation of chronic&#xD;
      obstructive pulmonary disease (COPD) caused by air pollution, and develop the corresponding&#xD;
      mobile medical assistant system. Through the cross fusion of existing information technology&#xD;
      and medical research results, an auxiliary medical system is formed for information&#xD;
      recording, tracking tools, early warning model and clinical diagnosis of patients with COPD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">December 30, 2018</completion_date>
  <primary_completion_date type="Actual">April 23, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of acute exacerbations</measure>
    <time_frame>1 year incidence rate</time_frame>
    <description>Frequency of acute exacerbations</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">56</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Low air pollution</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>High air pollution</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Types and exposure of different air pollutants</intervention_name>
    <description>Types and exposure of different air pollutants in COPD patients' living and working environment</description>
    <arm_group_label>High air pollution</arm_group_label>
    <arm_group_label>Low air pollution</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Stable chronic obstructive pulmonary disease (COPD) patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged &gt; 40 and &lt; 80 years with post-bronchodilator FEV1/ forced vital capacity&#xD;
             (FVC) &lt; 0.7 and percentage predicted of FEV1&gt;30%, who were no exacerbation of symptoms&#xD;
             in the 6 weeks preceding the study, were included in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who were diagnosed with other chronic respiratory diseases, including&#xD;
             bronchial asthma, bronchiectasis and lung abscess.&#xD;
&#xD;
          -  Patients with near-terminal illness, congestive heart failure (NYHA III-IV), or cannot&#xD;
             record CAT score timely were excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Yahong Chen, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 4, 2021</study_first_submitted>
  <study_first_submitted_qc>July 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2021</study_first_posted>
  <last_update_submitted>July 4, 2021</last_update_submitted>
  <last_update_submitted_qc>July 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

